JP2002521333A - 高眼圧治療用眼薬組成物 - Google Patents

高眼圧治療用眼薬組成物

Info

Publication number
JP2002521333A
JP2002521333A JP2000560892A JP2000560892A JP2002521333A JP 2002521333 A JP2002521333 A JP 2002521333A JP 2000560892 A JP2000560892 A JP 2000560892A JP 2000560892 A JP2000560892 A JP 2000560892A JP 2002521333 A JP2002521333 A JP 2002521333A
Authority
JP
Japan
Prior art keywords
formulation
treatment
weight
prostaglandin
carbonic anhydrase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000560892A
Other languages
English (en)
Japanese (ja)
Inventor
ポンテイセロ，ジエラルド・エス
スーグルー，マイケル・エフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JP2002521333A publication Critical patent/JP2002521333A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2000560892A 1998-07-21 1999-07-20 高眼圧治療用眼薬組成物 Withdrawn JP2002521333A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11995198A 1998-07-21 1998-07-21
US09/119,951 1998-07-21
PCT/US1999/016374 WO2000004899A1 (fr) 1998-07-21 1999-07-20 Compositions ophtalmiques destinees au traitement de l'hypertension oculaire

Publications (1)

Publication Number Publication Date
JP2002521333A true JP2002521333A (ja) 2002-07-16

Family

ID=22387375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000560892A Withdrawn JP2002521333A (ja) 1998-07-21 1999-07-20 高眼圧治療用眼薬組成物

Country Status (5)

Country Link
EP (1) EP1100491A1 (fr)
JP (1) JP2002521333A (fr)
AU (1) AU5114499A (fr)
CA (1) CA2337349A1 (fr)
WO (1) WO2000004899A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004528369A (ja) * 2001-05-03 2004-09-16 アラーガン、インコーポレイテッド 向上した薬物動態特性を有する組成物
WO2006035969A1 (fr) * 2004-09-28 2006-04-06 Senju Pharmaceutical Co., Ltd. Composition ophtalmique contenant de la gomme xanthane et un acide amine
WO2007108541A1 (fr) 2006-03-23 2007-09-27 Senju Pharmaceutical Co., Ltd. Composition ophtalmique comprenant de la gomme de xanthane et du glucose
JP2009512674A (ja) * 2005-10-24 2009-03-26 フォーチュン アペックス ディベロップメント リミテッド ヒドロキシプロピルメチルセルロースを含有する水性薬学的組成物の調製法およびそれにより得られる薬学的組成物

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
AU2001261360A1 (en) * 2000-05-10 2001-11-20 Alcon, Inc. R-eliprodil for treating glaucoma
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
JP4966854B2 (ja) 2005-07-11 2012-07-04 千寿製薬株式会社 キサンタンガムおよびテルペノイドを含有する点眼剤
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0664707B1 (fr) * 1992-10-13 1997-06-04 Alcon Laboratories, Inc. Combinaisons de prostaglandines et de derives de clonidine pour le traitement du glaucome

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004528369A (ja) * 2001-05-03 2004-09-16 アラーガン、インコーポレイテッド 向上した薬物動態特性を有する組成物
WO2006035969A1 (fr) * 2004-09-28 2006-04-06 Senju Pharmaceutical Co., Ltd. Composition ophtalmique contenant de la gomme xanthane et un acide amine
US7939511B2 (en) 2004-09-28 2011-05-10 Senju Pharmaceutical Co., Ltd. Ophthalmic composition containing xanthan gum and amino acid
JP2009512674A (ja) * 2005-10-24 2009-03-26 フォーチュン アペックス ディベロップメント リミテッド ヒドロキシプロピルメチルセルロースを含有する水性薬学的組成物の調製法およびそれにより得られる薬学的組成物
WO2007108541A1 (fr) 2006-03-23 2007-09-27 Senju Pharmaceutical Co., Ltd. Composition ophtalmique comprenant de la gomme de xanthane et du glucose

Also Published As

Publication number Publication date
WO2000004899A1 (fr) 2000-02-03
EP1100491A1 (fr) 2001-05-23
AU5114499A (en) 2000-02-14
CA2337349A1 (fr) 2000-02-03

Similar Documents

Publication Publication Date Title
JP2002521332A (ja) 高眼圧治療用眼薬組成物
US4599353A (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US5194429A (en) Ocular hypotensive agents
JP2002521333A (ja) 高眼圧治療用眼薬組成物
EP0580268B1 (fr) Agents oculaires hypotenseurs
US20110275711A1 (en) Method for treating macular edema
US6545045B1 (en) Prostaglandin E agonists for treatment of glaucoma
JP2002501533A (ja) 高眼圧症治療のための眼科用組成物
CA2146006C (fr) Utilisation de derives de l'ergoline dans le traitement du glaucome
US20020094981A1 (en) Ophthalmic compositions for treating ocular hypertension
US7005448B2 (en) Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
KR100788226B1 (ko) 15-케토-프로스타글란딘 또는 이의 유도체를 포함하는세포자연사 억제 조성물
TWI501769B (zh) 治療黃斑部病變用組成物
EP0590972B1 (fr) Traitement de l'hypertension oculaire avec une combinaison synergétique
US5236907A (en) Ocular hypotensive agents
US20050014837A1 (en) Method for treating ocular hypertension and glaucoma
JP4300347B2 (ja) ブナゾシンとプロスタグランジン類からなる緑内障治療剤
US20060211700A1 (en) (R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one for controlling IOP and treating glaucoma
US6420422B1 (en) Ocular hypotensive agents
JP2002501017A (ja) 視神経および網膜内の酸素圧を増加させるための方法
TW201545748A (zh) 伴隨老年性黃斑部病變的地圖狀萎縮的處置用的醫藥組成物

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20061003